BRIEF-Caris Life Sciences Announces Collaboration With Genentech Dec 16 (Reuters) - Caris Life Sciences Inc CAI.O:
CARIS LIFE SCIENCES ANNOUNCES COLLABORATION WITH GENENTECH TO DISCOVER NOVEL THERAPEUTIC TARGETS IN CANCERS WITH HIGH UNMET CLINICAL NEED
CARIS LIFE SCIENCES INC - ELIGIBLE FOR $25 MILLION UPFRONT AND $1.1 BILLION IN MILESTONES
Source text: ID:nPn1QqhHVa
Further company coverage: CAI.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments